home / stock / cnbx / cnbx news

CNBX News and Press, Cannabics Pharmaceuticals Inc From 10/27/20

Stock Information
Company Name: Cannabics Pharmaceuticals Inc
Stock Symbol: CNBX
Market: OTC
Website: cannabics.com
Menu
CNBX CNBX Quote CNBX Short CNBX News CNBX Articles CNBX Message Board
Get CNBX Alerts

News, Short Squeeze, Breakout and More Instantly...
CNBX - Cannabics Pharmaceuticals receives "Intention to Grant a European Patent" notice for its System and Method for High Throughput Screening of Cancer Cells patent application

Cannabics Pharmaceuticals receives "Intention to Grant a European Patent" notice for its System and Method for High Throughput Screening of Cancer Cells patent application PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, Oct. 27, 2020 TEL AVIV , Israel a...
CNBX - Cannabics Pharmaceuticals Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS(TM) RCC-33

Cannabics Pharmaceuticals Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33 PR Newswire TEL AVIV, Israel and BETHESDA, Md., Oct. 21, 2020 TEL AVIV , Israel and BETHESDA,&#...

CNBX - Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug Candidate RCC-33

TEL AVIV , Israel and BETHESDA, Maryland , Aug. 20, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it is establishing a dedicated division for the deve...

CNBX - Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), Gastroenterologist, to its Scientific Board of Advisors

TEL AVIV , Israel and BETHESDA, Md., Aug. 5, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has appointed Dr. Dana Ben-Ami Shor to its Scienti...
CNBX - Cannabics Pharmaceuticals Initiates Penetration for Its Cannabinoid Diagnostic Platform Into European Markets

TEL AVIV , Israel and BETHESDA, Maryland , July 14, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has initiated activities to penetrate European ma...

CNBX - Cannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of Advisors

TEL AVIV , Israel and BETHESDA, Maryland , June 16, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has appointed Dr. Erez Scapa to its Scient...

CNBX - Cannabics Pharmaceuticals and Cannomed Collaborate to Develop Cannabis Strains Targeting Cancers

TEL AVIV , Israel and BETHESDA, Maryland, June 10, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Understand...
CNBX - Cannabics Pharmaceuticals to Capitalize on Israel's Final Approval for the Export of Medical Cannabis

TEL AVIV, Israel and BETHESDA, Maryland , May 26, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the Israeli government has granted final approval for the expor...

CNBX - Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids

TEL AVIV , Israel and BETHESDA, Maryland , May 6, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has filed a Provisional Patent Application with the...

CNBX - Cannabics Pharmaceuticals Appoints Prof. Zamir Halpern to Its Scientific Board of Advisors

TEL AVIV , Israel and BETHESDA, Maryland , April 27, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has appointed Prof. Zamir Halpern to i...
Previous 10 Next 10